PD Dr. Markus Eckstein

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer (2021) Wahby S, Jarczyk J, Fierek A, Heinkele J, Weis CA, Eckstein M, Martini T, et al. Journal article Heterogeneity-analysis of molecular subtypes of muscle-invasive bladder cancer and their precursor lesions in multiregion mapped whole-organ bladders (2020) Weyerer V, Lange F, Wullweber A, Stöhr R, Bertz S, Wach S, Taubert H, et al. Conference contribution Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer (2020) Wu S, Nitschke K, Worst TS, Fierek A, Weis CA, Eckstein M, Porubsky S, et al. Journal article Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer (2020) Devlies W, Eckstein M, Cimadamore A, Devos G, Moris L, Van Den Broeck T, Montironi R, et al. Journal article, Review article Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Conference contribution High stroma T-cell infiltration is associated with better survival in stage pT1 bladder cancer (2020) Hülsen S, Lippolis E, Ferrazzi F, Otto W, Distel L, Fietkau R, Denzinger S, et al. Journal article Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy (2020) Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, et al. Journal article Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors (2020) Schubert P, Rutzner S, Eckstein M, Frey B, Schweizer C, Haderlein M, Lettmaier S, et al. Journal article Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8 (2020) Hecht M, Gostian AO, Eckstein M, Rutzner S, von der Grün J, Illmer T, Hautmann MG, et al. Journal article Analysis of CXCL9, PD1 and PD-L1 mRNA in stage T1 non-muscle invasive bladder cancer and their association with prognosis (2020) Kubon J, Sikic D, Eckstein M, Weyerer V, Stöhr R, Neumann A, Keck B, et al. Journal article